Olfactory reference syndrome
Olfactory Reference Syndrome (ORS) is a psychiatric condition where the affected individual is persistently preoccupied with the belief that they emit a foul or offensive body odor, which is not perceived by others. This condition is often associated with significant distress and functional impairment.
Definition[edit]
Olfactory Reference Syndrome (ORS) is a condition characterized by an individual's persistent belief that they emit a foul or unpleasant odor. The perceived odor is not detectable by others. This condition is often associated with significant distress and functional impairment.
Symptoms[edit]
The primary symptom of ORS is the persistent belief in having a foul or unpleasant body odor. This belief often leads to excessive personal hygiene practices, such as frequent showering or excessive use of deodorants. The individual may also engage in repetitive behaviors, such as frequent checking for body odor or asking others for reassurance about the non-existent odor.
Causes[edit]
The exact cause of ORS is unknown. However, it is believed to be associated with a variety of factors, including genetic predisposition, environmental factors, and psychological factors. Some studies suggest that ORS may be related to obsessive-compulsive disorder (OCD) or body dysmorphic disorder (BDD).
Treatment[edit]
Treatment for ORS typically involves cognitive-behavioral therapy (CBT), which can help the individual to challenge their beliefs about their body odor and reduce their compulsive behaviors. In some cases, medication may also be used as part of the treatment plan.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
